oligo peptide drug conjugate targeting transferrin receptor (PeptiDream/Takeda/Alnylam)

N/A

Report date: 2025/06/11 11:17:53

Base Information

Drug Nameoligo peptide drug conjugate targeting transferrin receptor (PeptiDream/Takeda/Alnylam)
Drug Alias NameTfR Oligo-PDC
ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting products > Radioactive therapeutic agentDiagnostic agent (In vivo)
Mechanisms of ActionNeuroprotectantsTransferrin receptors modulators
TargetsTransferrin receptors
Therapy Area/IndicationsNeuromuscular DiseasesCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncAlnylam Pharmaceuticals IncTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeuromuscular DiseasesCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A